An editorial on UK digital hepatology highlights the diagnostic and prognostic value of LiverMultiScan and MRCP+ in AILDs. LiverMultiScan’s cT1 has a prognostic value as it correlates with the risk of loss of biochemical remission in AIH. MRCP+ correlates with validated risk scoring systems and may improve diagnosis and prognostic models in primary PSC.